Nuclear Medicine
DMSA
Name:
DMSA-Sn Radiofarma® TC
Active Principle:
Dimercap Succinic Acid
Therapeutic Action:
It is indicated for renal scintigraphy by means of static (planar or tomographic) and dynamic images of the kidney by scintigraphy; whether they are morphological studies of the renal cortex, function of the individual kidney or location of the ectopic kidney.
Nuclear Medicine
DMSA
Name:
DMSA-Sn Radiofarma® TC
Active Principle:
Dimercap Succinic Acid
Therapeutic Action:
It is indicated for renal scintigraphy by means of static (planar or tomographic) and dynamic images of the kidney by scintigraphy; whether they are morphological studies of the renal cortex, function of the individual kidney or location of the ectopic kidney.
RELATED PRODUCTS
-
123I MIBG BACON (R&D)
123I MIBG BACON (R&D)It is indicated for: Oncology: a) Scintigraphic localization of tumors originating in tissues that derive embryologically from the neural crest... -
131I MIBG BACON (R&D)
131I MIBG BACON (R&D)It is indicated for the diagnosis and location of neuroendocrine tumors, pheochromocytoma, medullary thyroid cancer, primary neuroblastomas and their metastases, paragangliomas and thymomas... -
FLPET (R+D)
FLPET (R+D)It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness...

